Hep C Update: New Evidence for Milk Thistle
A recent study from Columbia University Medical Center on milk thistle gives those who are unsure about using herbal supplements for Hepatitis C reason to reconsider.
Continue reading »Research & Treatment News
Share
Follow Us
New Hepatitis C Drug Combinations
Combined with interferon and ribavirin, clinical trials on Vertex's telaprevir demonstrate twice the success rate in clearing Hepatitis C in half the time as traditional combination therapy. While this alone is exciting, Vertex is exploring a range of drug combination options for battling the Hepatitis C virus.
Continue reading »Triple Therapy Reduces Hepatitis C Drug Resistance
A review in the February 2010 issue of Gastroenterology cites viral resistance against new medications as incentive for using triple therapy to treat Hepatitis C.
Continue reading »Three HCV Drug Candidates Proceed to Phase II
Hepatitis C drug candidates ABT-450, ABT-333 and ABT-072 move into Phase II testing.
Continue reading »Should Those with HCV Be Concerned About Bathing?
Find out how some with Hepatitis C unintentionally expose their skin to bath water contaminants that can place an additional burden on their liver.
Continue reading »Long Wait for Hep C Treatment in Queensland
Those who are educated about Hepatitis C know that time is of the essence when it comes to receiving treatment. Unfortunately, some Australians with this virus have to wait a reported six years to see a specialist.
Continue reading »The Relationship Between Hepatitis C and Crying
While there are several notable exceptions, discover four significant ways that crying can help someone with Hepatitis C.
Continue reading »Altered Mice Offer Ideal Liver Disease Drug Testing Model
Solving the ongoing challenge of how to test potential liver disease drugs before experimenting on humans, Salk Institute researchers have perfected a system where medications can be tested in mice with mostly human livers.
Continue reading »HCV Treatment-Induced Anemia Predicted by Genetics
Thanks to research from Duke University's Institute for Genome Sciences & Policy, scientists have confirmed that some individuals have genetic protection against ribavirin-induced anemia. Since ribavirin is part of the standard Hepatitis C treatment protocol, this discovery will better enable physicians to foretell who can best withstand Hepatitis C therapy.
Continue reading »Easing Liver Inflammation: Balancing Omega-3's and Omega-6's
Although both are required for a healthy immune response, learn why those with inflammation of the liver should favor omega-3 fatty acids over omega-6's.
Continue reading »
